GTHX vs. XBI
Compare and contrast key facts about G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GTHX or XBI.
Correlation
The correlation between GTHX and XBI is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GTHX vs. XBI - Performance Comparison
Key characteristics
Returns By Period
GTHX
N/A
N/A
N/A
N/A
N/A
N/A
XBI
-10.89%
-6.17%
-17.39%
-3.74%
-3.91%
1.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GTHX vs. XBI — Risk-Adjusted Performance Rank
GTHX
XBI
GTHX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GTHX vs. XBI - Dividend Comparison
GTHX has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.17%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTHX G1 Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.17% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
GTHX vs. XBI - Drawdown Comparison
Volatility
GTHX vs. XBI - Volatility Comparison
The current volatility for G1 Therapeutics, Inc. (GTHX) is 0.00%, while SPDR S&P Biotech ETF (XBI) has a volatility of 15.13%. This indicates that GTHX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.